INCB013739 treatment of type 2 diabetes mellitus patients who failed on metformin monotherapy show significantly improved hepatic and peripheral insulin sensitivity and reduced haemoglobin A1c and fasting plasma glucose levels. The gene discussed is INS; the disease is type 2 diabetes mellitus.